Pages

▼
Thursday, April 24, 2025

Sana Biotechnology Reports First Results For Islet Transplants Without Immunosuppression

›
This blog post reports on some news that I consider exciting, for at least two different reasons: first because it might be an early milesto...
1 comment:
Tuesday, March 18, 2025

TIXIMED Starts a Phase 1 Study of TIX100

›
TIX100 is a protein which inhibits the action of TIXNP (thioredoxin-interacting protein).  It is being developed by the TIXIMED company.  TX...
Friday, March 7, 2025

Combination of Harmine and GLP-1RA Completes Phase-I Clinical Trial (In Healthy People)

›
This is the most fun I have had writing a blog in a long time.  It is not often I can blog about psychedelics and curing type-1 diabetes at ...
4 comments:
Friday, January 31, 2025

Denosumab Starts A Phase-I Trial In People With Established T1D

›
Denosumab is a monoclonal antibody, which is already approved for several bone related diseases and is sold under the names Wyost, Xgeva, Pr...
Sunday, January 19, 2025

What To Watch In 2025

›
Last year, at the start of the year, I published a blog of four research projects I was looking forward to updates in the new year.  This ye...
Tuesday, December 31, 2024

Breakthrough T1D (formerly JDRF) Funding for a Cure 2024

›
Normally, sometime in October, I write a summary of all the clinical trials funded by JDRF.   However, this year I didn't, which was a m...
Monday, December 23, 2024

Fenofibrate Is Unsuccessful In A Phase-IIΔ Trial In Honeymooners

›
Fenofibrate (also spelled Phenofibrate) is commonly prescribed for high cholesterol and high triglycerides. In 2017, it was the 70th most co...